Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11401286 Heteroaryl inhibitors of PDE4

Patent 11401286 was granted and assigned to Tetra Therapeutics on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Tetra Therapeutics

0

Current Assignee

Tetra Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Donna L. Romero0

A. Samuel Vellekoop0

Xuesheng Mo0

Timothy J. Hagen0

Robert Campbell0

Mark E. Gurney0

Lei Zhu0

Joel R. Walker0

Date of Patent

August 2, 2022

0

Patent Application Number

167817480

Date Filed

February 4, 2020

0

Patent Citations

US Patent 10093686 Heteroaryl inhibitors of PDE4

0

US Patent 10364258 Heteroaryl inhibitors of PDE4

US Patent 10626129 Heteroaryl inhibitors of PDE4

0

Patent Citations Received

US Patent 11767334 Heteroaryl inhibitors of PDE4

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11401286 Heteroaryl inhibitors of PDE4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.